{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:54:23Z","timestamp":1794351263409,"version":"4.9.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06052-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:51:28Z","timestamp":1784123488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exosome Biology at the Interface of Neurodegeneration and Therapeutic Innovation"],"prefix":"10.1007","volume":"63","author":[{"given":"Dipan","family":"Maity","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gowtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"6052_CR1","doi-asserted-by":"crossref","unstructured":"Javaid SF, Giebel C, Khan MA, Hashim MJ (2021) Epidemiology of Alzheimer\u2019s disease and other dementias: rising global burden and forecasted trends [version 1; peer review: 1 approved with reservations]. F1000Research 10:425","DOI":"10.12688\/f1000research.50786.1"},{"key":"6052_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2026.100421","volume":"14","author":"S Wang","year":"2026","unstructured":"Wang S et al (2026) Epidemiology of Parkinson\u2019s disease \u2013 global burden of disease research from 1990 to 2021 and future trend predictions. Clin Parkinsonism Relat Disord 14:100421","journal-title":"Clin Parkinsonism Relat Disord"},{"issue":"6","key":"6052_CR3","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","volume":"101","author":"C Wolfson","year":"2023","unstructured":"Wolfson C et al (2023) Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review. Neurology 101(6):e613\u2013e623","journal-title":"Neurology"},{"key":"6052_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020434","author":"C Caruso Bavisotto","year":"2019","unstructured":"Caruso Bavisotto C et al (2019) Extracellular vesicle-mediated cell\u207bcell communication in the nervous system: focus on neurological diseases. Int J Mol Sci\u00a0","journal-title":"Int J Mol Sci"},{"key":"6052_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139206","volume":"292","author":"A Gowtham","year":"2025","unstructured":"Gowtham A, Kaundal RK (2025) Exploring the ncRNA landscape in exosomes: insights into wound healing mechanisms and therapeutic applications. Int J Biol Macromol 292:139206","journal-title":"Int J Biol Macromol"},{"key":"6052_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19","journal-title":"Cell Biosci"},{"issue":"8","key":"6052_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1096\/fba.2021-00035","volume":"3","author":"A Schnatz","year":"2021","unstructured":"Schnatz A et al (2021) Extracellular vesicles in neural cell interaction and CNS homeostasis. FASEB Bioadv 3(8):577\u2013592","journal-title":"FASEB Bioadv"},{"issue":"4","key":"6052_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbrc.2016.09.090","volume":"483","author":"C Quek","year":"2017","unstructured":"Quek C, Hill AF (2017) The role of extracellular vesicles in neurodegenerative diseases. Biochem Biophys Res Commun 483(4):1178\u20131186","journal-title":"Biochem Biophys Res Commun"},{"key":"6052_CR9","doi-asserted-by":"publisher","unstructured":"Rani P, Karthik S, Srisharnitha AS (2020) Molecular signatures in exosomes as diagnostic markers for neurodegenerative disorders. Ann Alzheimers Dement Care 4(1):12\u201317. https:\/\/doi.org\/10.17352\/aadc.000012","DOI":"10.17352\/aadc.000012"},{"key":"6052_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.47184\/tev.2020.01.06","volume":"2","author":"J Gross","year":"2020","unstructured":"Gross J, Parbin S (2020) Crossroads of the endosomal machinery: multivesicular bodies, small extracellular vesicles and autophagy. Trillium Exctracellular Vesicles 2:48\u201353","journal-title":"Trillium Exctracellular Vesicles"},{"issue":"17","key":"6052_CR11","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1016\/j.cub.2021.06.022","volume":"31","author":"P Perrin","year":"2021","unstructured":"Perrin P et al (2021) Retrofusion of intralumenal MVB membranes parallels viral infection and coexists with exosome release. Curr Biol 31(17):3884-3893.e4","journal-title":"Curr Biol"},{"issue":"1","key":"6052_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/cdd.2008.168","volume":"16","author":"CM Fader","year":"2009","unstructured":"Fader CM, Colombo MI (2009) Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 16(1):70\u201378","journal-title":"Cell Death Differ"},{"issue":"1","key":"6052_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21(1):207","journal-title":"Mol Cancer"},{"issue":"1","key":"6052_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4161\/cib.18208","volume":"5","author":"JR Mayers","year":"2012","unstructured":"Mayers JR, Audhya A (2012) Vesicle formation within endosomes: an ESCRT marks the spot. Commun Integr Biol 5(1):50\u201356","journal-title":"Commun Integr Biol"},{"key":"6052_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102014","volume":"20","author":"FG Ortega","year":"2019","unstructured":"Ortega FG et al (2019) Interfering with endolysosomal trafficking enhances release of bioactive exosomes. Nanomedicine (Lond) 20:102014","journal-title":"Nanomedicine (Lond)"},{"issue":"6","key":"6052_CR16","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bpj.2017.05.032","volume":"113","author":"CE Jackson","year":"2017","unstructured":"Jackson CE et al (2017) Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis. Biophys J 113(6):1342\u20131352","journal-title":"Biophys J"},{"issue":"4","key":"6052_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2023.01.006","volume":"58","author":"YJ Lee","year":"2023","unstructured":"Lee YJ et al (2023) GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell 58(4):320-334.e8","journal-title":"Dev Cell"},{"issue":"7","key":"6052_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2502","volume":"14","author":"MF Baietti","year":"2012","unstructured":"Baietti MF et al (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14(7):677\u2013685","journal-title":"Nat Cell Biol"},{"key":"6052_CR19","doi-asserted-by":"crossref","unstructured":"Choezom D, Gross JC (2022) Neutral sphingomyelinase 2 controls exosome secretion by counteracting V ATPase mediated endosome acidification. J Cell Sci 135(5):jcs259324","DOI":"10.1242\/jcs.259324"},{"key":"6052_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.26.542409","author":"Y Ai","year":"2023","unstructured":"Ai Y et al (2023) Syntenin and CD63 promote exosome biogenesis from the plasma membrane by blocking cargo endocytosis. bioRxiv","journal-title":"bioRxiv"},{"issue":"17","key":"6052_CR21","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1074\/jbc.M112.445304","volume":"288","author":"D Perez-Hernandez","year":"2013","unstructured":"Perez-Hernandez D et al (2013) The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem 288(17):11649\u201311661","journal-title":"J Biol Chem"},{"issue":"1","key":"6052_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yexcr.2019.04.010","volume":"380","author":"KL Zulkefli","year":"2019","unstructured":"Zulkefli KL et al (2019) A role for Rab11 in the homeostasis of the endosome-lysosomal pathway. Exp Cell Res 380(1):55\u201368","journal-title":"Exp Cell Res"},{"issue":"2","key":"6052_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-020-00409-1","volume":"31","author":"D Wei","year":"2021","unstructured":"Wei D et al (2021) RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res 31(2):157\u2013177","journal-title":"Cell Res"},{"issue":"3","key":"6052_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12311","volume":"12","author":"PP Marie","year":"2023","unstructured":"Marie PP et al (2023) Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formation. J Extracell Vesicles 12(3):e12311","journal-title":"J Extracell Vesicles"},{"issue":"23","key":"6052_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/app122312259","volume":"12","author":"J Rech","year":"2022","unstructured":"Rech J et al (2022) Origin and composition of exosomes as crucial factors in designing drug delivery systems. Appl Sci (Basel) 12(23):12259","journal-title":"Appl Sci (Basel)"},{"issue":"Pt 13","key":"6052_CR26","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1242\/jcs.110.13.1431","volume":"110","author":"P Liang","year":"1997","unstructured":"Liang P, MacRae TH (1997) Molecular chaperones and the cytoskeleton. J Cell Sci 110(Pt 13):1431\u20131440","journal-title":"J Cell Sci"},{"issue":"11","key":"6052_CR27","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1091\/mbc.e08-03-0239","volume":"19","author":"T Falgui\u00e8res","year":"2008","unstructured":"Falgui\u00e8res T et al (2008) In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101. Mol Biol Cell 19(11):4942\u20134955","journal-title":"Mol Biol Cell"},{"issue":"6","key":"6052_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","volume":"23","author":"FG Kugeratski","year":"2021","unstructured":"Kugeratski FG et al (2021) Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker. Nat Cell Biol 23(6):631\u2013641","journal-title":"Nat Cell Biol"},{"issue":"1","key":"6052_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu M et al (2021) Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun 12(1):4389","journal-title":"Nat Commun"},{"key":"6052_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.47184\/tev.2020.01.08","volume":"2","author":"P Altevogt","year":"2020","unstructured":"Altevogt P et al (2020) Perspective\u2014escape from destruction: how cancer-derived EVs are protected from phagocytosis. Trillium Extracell Veiscles 2:60\u201364","journal-title":"Trillium Extracell Veiscles"},{"issue":"11","key":"6052_CR31","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","volume":"23","author":"SM Kong","year":"2014","unstructured":"Kong SM et al (2014) Parkinson\u2019s disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes \u03b1-Synuclein externalization via exosomes. Hum Mol Genet 23(11):2816\u20132833","journal-title":"Hum Mol Genet"},{"key":"6052_CR32","doi-asserted-by":"crossref","unstructured":"Th\u00e9ry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi Castagnoli P, Raposo G, Amigorena S (1999) Molecular characterization of dendritic cell derived exosomes. Selective accumulation of the heat shock protein Hsc73. J Cell Biol 147(3): 599\u2013610","DOI":"10.1083\/jcb.147.3.599"},{"issue":"1","key":"6052_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bcmd.2005.04.001","volume":"35","author":"J Mallegol","year":"2005","unstructured":"Mallegol J, van Niel G, Heyman M (2005) Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol Dis 35(1):11\u201316","journal-title":"Blood Cells Mol Dis"},{"key":"6052_CR34","doi-asserted-by":"crossref","unstructured":"Wubbolts R, Leckie RS, Veenhuizen PTM, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W (2003) Proteomic and biochemical analyses of human B cell derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278(13):10963\u201372","DOI":"10.1074\/jbc.M207550200"},{"key":"6052_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311054","author":"A He","year":"2023","unstructured":"He A et al (2023) Role of exosomes in the pathogenesis and theranostic of Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241311054","journal-title":"Int J Mol Sci"},{"key":"6052_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122028","author":"X Yu","year":"2016","unstructured":"Yu X, Odenthal M, Fries JW (2016) Exosomes as miRNA carriers: formation-function-future. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17122028","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6052_CR37","doi-asserted-by":"publisher","first-page":"FSO465","DOI":"10.2144\/fsoa-2019-0116","volume":"6","author":"N Dilsiz","year":"2020","unstructured":"Dilsiz N (2020) Role of exosomes and exosomal microRNAs in cancer. Future Sci OA 6(4):FSO465","journal-title":"Future Sci OA"},{"issue":"3","key":"6052_CR38","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/jcp.29153","volume":"235","author":"A Sharma","year":"2020","unstructured":"Sharma A, Johnson A (2020) Exosome DNA: critical regulator of tumor immunity and a diagnostic biomarker. J Cell Physiol 235(3):1921\u20131932","journal-title":"J Cell Physiol"},{"key":"6052_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101557","author":"Q Li","year":"2019","unstructured":"Li Q et al (2019) Exosomes: versatile nano mediators of immune regulation. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11101557","journal-title":"Cancers (Basel)"},{"key":"6052_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2015.02.009","volume":"40","author":"DW Greening","year":"2015","unstructured":"Greening DW et al (2015) Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol 40:72\u201381","journal-title":"Semin Cell Dev Biol"},{"key":"6052_CR41","doi-asserted-by":"publisher","unstructured":"Han W, Zhang H, Feng L, Dang R, Wang J, Cui C, Jiang P (2023) The emerging role of exosomes in communication between the periphery and the central nervous system. MedComm 4:e410. https:\/\/doi.org\/10.1002\/mco2.410","DOI":"10.1002\/mco2.410"},{"key":"6052_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115635","author":"Z Osaid","year":"2023","unstructured":"Osaid Z et al (2023) Exosomes interactions with the blood-brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242115635","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"6052_CR43","first-page":"1","volume":"10","author":"C Lafourcade","year":"2016","unstructured":"Lafourcade C et al (2016) MiRNAs in astrocyte-derived exosomes as possible mediators of neuronal plasticity. J Exp Neurosci 10(Suppl 1):1\u20139","journal-title":"J Exp Neurosci"},{"issue":"8","key":"6052_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/14728222.2018.1501473","volume":"22","author":"S Ranjit","year":"2018","unstructured":"Ranjit S et al (2018) Potential neuroprotective role of astroglial exosomes against smoking-induced oxidative stress and HIV-1 replication in the central nervous system. Expert Opin Ther Targets 22(8):703\u2013714","journal-title":"Expert Opin Ther Targets"},{"key":"6052_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.630808","volume":"14","author":"M Guo","year":"2021","unstructured":"Guo M et al (2021) Microglial exosomes in neurodegenerative disease. Front Mol Neurosci 14:630808","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"6052_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000621","volume":"18","author":"C Fr\u00fchbeis","year":"2020","unstructured":"Fr\u00fchbeis C et al (2020) Oligodendrocytes support axonal transport and maintenance via exosome secretion. PLoS Biol 18(12):e3000621","journal-title":"PLoS Biol"},{"key":"6052_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.601600","volume":"9","author":"P Yuan","year":"2021","unstructured":"Yuan P et al (2021) Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Front Cell Dev Biol 9:601600","journal-title":"Front Cell Dev Biol"},{"key":"6052_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114161","volume":"159","author":"M Ozansoy","year":"2023","unstructured":"Ozansoy M et al (2023) Exosomes: a missing link between chronic systemic inflammation and Alzheimer\u2019s disease? Biomed Pharmacother 159:114161","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6052_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","volume":"136","author":"M Sardar Sinha","year":"2018","unstructured":"Sardar Sinha M et al (2018) Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol 136(1):41\u201356","journal-title":"Acta Neuropathol"},{"issue":"30","key":"6052_CR50","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L et al (2006) Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103(30):11172\u201311177","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"6052_CR51","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41374-021-00644-z","volume":"101","author":"E Miyoshi","year":"2021","unstructured":"Miyoshi E et al (2021) Exosomal tau with seeding activity is released from Alzheimer\u2019s disease synapses, and seeding potential is associated with amyloid beta. Lab Invest 101(12):1605\u20131617","journal-title":"Lab Invest"},{"issue":"6","key":"6052_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1567205016666190321154618","volume":"16","author":"E Paouri","year":"2019","unstructured":"Paouri E, Georgopoulos S (2019) Systemic and CNS inflammation crosstalk: implications for Alzheimer\u2019s disease. Curr Alzheimer Res 16(6):559\u2013574","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"6052_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.258","volume":"5","author":"R Park","year":"2014","unstructured":"Park R et al (2014) A\u03b21-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling. Cell Death Dis 5(6):e1299","journal-title":"Cell Death Dis"},{"key":"6052_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081800","author":"Y Zhao","year":"2022","unstructured":"Zhao Y et al (2022) A\u03b2 and tau regulate microglia metabolism via exosomes in Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10081800","journal-title":"Biomedicines"},{"key":"6052_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221834","author":"M Ghosh","year":"2024","unstructured":"Ghosh M, Pearse DD (2024) The yin and yang of microglia-derived extracellular vesicles in CNS injury and diseases. Cells. https:\/\/doi.org\/10.3390\/cells13221834","journal-title":"Cells"},{"key":"6052_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-026-03763-w","author":"J Zhang","year":"2026","unstructured":"Zhang J et al (2026) Molecular mechanisms and therapeutic potential of tryptophan metabolism in gut-brain signaling transduction: a narrative review. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-026-03763-w","journal-title":"J Neuroinflammation"},{"key":"6052_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-026-03844-w","author":"Y Chen","year":"2026","unstructured":"Chen Y et al (2026) SGK1 inhibition supports neuroprotection in spinal cord injury by suppressing oxidative stress and AIM2 activation via FoxO1 mediated mitophagy. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-026-03844-w","journal-title":"J Neuroinflammation"},{"key":"6052_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.933979","volume":"14","author":"S Cazzaro","year":"2022","unstructured":"Cazzaro S et al (2022) Slingshot homolog-1 mediates the secretion of small extracellular vesicles containing misfolded proteins by regulating autophagy cargo receptors and actin dynamics. Front Aging Neurosci 14:933979","journal-title":"Front Aging Neurosci"},{"key":"6052_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM et al (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42","journal-title":"Mol Neurodegener"},{"issue":"9","key":"6052_CR60","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.4103\/1673-5374.335143","volume":"17","author":"KL Li","year":"2022","unstructured":"Li KL et al (2022) Role of exosomes in the pathogenesis of inflammation in Parkinson\u2019s disease. Neural Regen Res 17(9):1898\u20131906","journal-title":"Neural Regen Res"},{"issue":"1","key":"6052_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G et al (2018) Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy 14(1):98\u2013119","journal-title":"Autophagy"},{"issue":"20","key":"6052_CR62","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851","journal-title":"J Neurosci"},{"issue":"3","key":"6052_CR63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42(3):360\u2013367","journal-title":"Neurobiol Dis"},{"key":"6052_CR64","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fnmol.2019.00200","volume":"12","author":"V Sackmann","year":"2019","unstructured":"Sackmann V et al (2019) Inhibition of nSMase2 reduces -the transfer of oligomeric \u03b1-synuclein irrespective of hypoxia. Front Mol Neurosci 12:200","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"6052_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13041-021-00776-9","volume":"14","author":"C Zhu","year":"2021","unstructured":"Zhu C et al (2021) Pharmacological inhibition of nSMase2 reduces brain exosome release and \u03b1-synuclein pathology in a Parkinson\u2019s disease model. Mol Brain 14(1):70","journal-title":"Mol Brain"},{"issue":"9","key":"6052_CR66","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1073\/pnas.1312245111","volume":"111","author":"LI Grad","year":"2014","unstructured":"Grad LI et al (2014) Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 111(9):3620\u20133625","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 12","key":"6052_CR67","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139(Pt 12):3187\u20133201","journal-title":"Brain"},{"issue":"3","key":"6052_CR68","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.celrep.2016.09.032","volume":"17","author":"T Westergard","year":"2016","unstructured":"Westergard T et al (2016) Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS\/FTD. Cell Rep 17(3):645\u2013652","journal-title":"Cell Rep"},{"issue":"22","key":"6052_CR69","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1074\/jbc.M112.425066","volume":"288","author":"M Basso","year":"2013","unstructured":"Basso M et al (2013) Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 288(22):15699\u201315711","journal-title":"J Biol Chem"},{"issue":"27","key":"6052_CR70","doi-asserted-by":"publisher","first-page":"24178","DOI":"10.18632\/oncotarget.4680","volume":"6","author":"X Ding","year":"2015","unstructured":"Ding X et al (2015) Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget 6(27):24178\u201324191","journal-title":"Oncotarget"},{"key":"6052_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neures.2019.10.010","volume":"160","author":"N Hayashi","year":"2020","unstructured":"Hayashi N et al (2020) Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci Res 160:43\u201349","journal-title":"Neurosci Res"},{"key":"6052_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.637548","volume":"15","author":"A Schmitz","year":"2021","unstructured":"Schmitz A et al (2021) Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS\/FTD. Front Cell Neurosci 15:637548","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"6052_CR73","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/glia.22558","volume":"61","author":"MA Lopez-Verrilli","year":"2013","unstructured":"Lopez-Verrilli MA, Picou F, Court FA (2013) Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia 61(11):1795\u20131806","journal-title":"Glia"},{"key":"6052_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050845","author":"E Anakor","year":"2022","unstructured":"Anakor E et al (2022) The neurotoxicity of vesicles secreted by ALS patient myotubes is specific to exosome-like and not larger subtypes. Cells. https:\/\/doi.org\/10.3390\/cells11050845","journal-title":"Cells"},{"issue":"11","key":"6052_CR75","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/jnnp-2013-307135","volume":"85","author":"A Eisen","year":"2014","unstructured":"Eisen A et al (2014) Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 85(11):1232\u20131238","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6052_CR76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fnagi.2019.00074","volume":"11","author":"L Younes","year":"2019","unstructured":"Younes L et al (2019) Identifying changepoints in biomarkers during the preclinical phase of Alzheimer\u2019s disease. Front Aging Neurosci 11:74","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"6052_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40572-019-00233-9","volume":"6","author":"D Rokad","year":"2019","unstructured":"Rokad D et al (2019) Exosomes as mediators of chemical-induced toxicity. Curr Environ Health Rep 6(3):73\u201379","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"6052_CR78","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1038\/s41467-019-11486-1","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D et al (2019) Profiling surface proteins on individual exosomes using a proximity barcoding assay. Nat Commun 10(1):3854","journal-title":"Nat Commun"},{"issue":"3","key":"6052_CR79","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1074\/mcp.M116.064725","volume":"16","author":"P Larssen","year":"2017","unstructured":"Larssen P et al (2017) Tracing cellular origin of human exosomes using multiplex proximity extension assays. Mol Cell Proteomics 16(3):502\u2013511","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"6052_CR80","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L et al (2019) Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement 15(8):1071\u20131080","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6052_CR81","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-017-02533-w","volume":"9","author":"AM Miranda","year":"2018","unstructured":"Miranda AM et al (2018) Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures. Nat Commun 9(1):291","journal-title":"Nat Commun"},{"issue":"1","key":"6052_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl EJ et al (2015) Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85(1):40\u201347","journal-title":"Neurology"},{"issue":"11","key":"6052_CR83","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4103\/1673-5374.335832","volume":"17","author":"WL Liu","year":"2022","unstructured":"Liu WL et al (2022) Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer\u2019s disease: a meta-analysis and systematic review. Neural Regen Res 17(11):2381\u20132390","journal-title":"Neural Regen Res"},{"issue":"7","key":"6052_CR84","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1007\/s12035-021-02323-y","volume":"58","author":"Z Dong","year":"2021","unstructured":"Dong Z et al (2021) Profiling of serum exosome miRNA reveals the potential of a miRNA panel as diagnostic biomarker for Alzheimer\u2019s disease. Mol Neurobiol 58(7):3084\u20133094","journal-title":"Mol Neurobiol"},{"issue":"9","key":"6052_CR85","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","volume":"1862","author":"S Kumar","year":"2016","unstructured":"Kumar S, Reddy PH (2016) Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease? Biochim Biophys Acta 1862(9):1617\u20131627","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"6052_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13195-022-01133-1","volume":"14","author":"H Cai","year":"2022","unstructured":"Cai H et al (2022) Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer\u2019s disease. Alzheimers Res Ther 14(1):181","journal-title":"Alzheimers Res Ther"},{"key":"6052_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.565479","volume":"11","author":"Z Song","year":"2020","unstructured":"Song Z et al (2020) Comprehensive proteomic profiling of urinary exosomes and identification of potential non-invasive early biomarkers of Alzheimer\u2019s disease in 5XFAD mouse model. Front Genet 11:565479","journal-title":"Front Genet"},{"key":"6052_CR88","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"ZH Zhao","year":"2018","unstructured":"Zhao ZH et al (2018) Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease. Front Aging Neurosci 10:438","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"6052_CR89","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/agm2.12192","volume":"5","author":"S Kharel","year":"2022","unstructured":"Kharel S et al (2022) Salivary alpha-synuclein as a potential fluid biomarker in Parkinson\u2019s disease: a systematic review and meta-analysis. Aging Med (Milton) 5(1):53\u201362","journal-title":"Aging Med (Milton)"},{"issue":"10","key":"6052_CR90","volume":"14","author":"P Muddaloor","year":"2022","unstructured":"Muddaloor P et al (2022) Prospect of alpha-synuclein (A-Syn) isolation from saliva as a promising diagnostic biomarker alternative in Parkinson\u2019s disease (PD): a systematic review. Cureus 14(10):e29880","journal-title":"Cureus"},{"issue":"12","key":"6052_CR91","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.4103\/NRR.NRR-D-23-01677","volume":"19","author":"MI De Bartolo","year":"2024","unstructured":"De Bartolo MI et al (2024) A systematic review of salivary biomarkers in Parkinson\u2019s disease. Neural Regen Res 19(12):2613\u20132625","journal-title":"Neural Regen Res"},{"issue":"1","key":"6052_CR92","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es P, Lashuel HA (2022) Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. NPJ Parkinsons Dis 8(1):93","journal-title":"NPJ Parkinsons Dis"},{"key":"6052_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/cells13040340","author":"K Nijakowski","year":"2024","unstructured":"Nijakowski K et al (2024) Salivary biomarkers for Parkinson\u2019s disease: a systematic review with meta-analysis. Cells. https:\/\/doi.org\/10.3390\/cells13040340","journal-title":"Cells"},{"issue":"10","key":"6052_CR94","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/mds.26686","volume":"31","author":"KB Fraser","year":"2016","unstructured":"Fraser KB et al (2016) Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson\u2019s disease. Mov Disord 31(10):1543\u20131550","journal-title":"Mov Disord"},{"issue":"6","key":"6052_CR95","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/ene.14208","volume":"27","author":"M Niu","year":"2020","unstructured":"Niu M et al (2020) A longitudinal study on \u03b1-synuclein in plasma neuronal exosomes as a biomarker for Parkinson\u2019s disease development and progression. Eur J Neurol 27(6):967\u2013974","journal-title":"Eur J Neurol"},{"issue":"11","key":"6052_CR96","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/mds.28591","volume":"36","author":"C Jiang","year":"2021","unstructured":"Jiang C et al (2021) Validation of \u03b1-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes. Mov Disord 36(11):2663\u20132669","journal-title":"Mov Disord"},{"issue":"6","key":"6052_CR97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman M et al (2021) L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods 18(6):631\u2013634","journal-title":"Nat Methods"},{"issue":"8","key":"6052_CR98","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1007\/s12035-025-04909-2","volume":"62","author":"V Kadam","year":"2025","unstructured":"Kadam V et al (2025) Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC-derived neurons. Mol Neurobiol 62(8):10427\u201310442","journal-title":"Mol Neurobiol"},{"issue":"6","key":"6052_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12459","volume":"13","author":"CJ Nogueras-Ortiz","year":"2024","unstructured":"Nogueras-Ortiz CJ et al (2024) Single-extracellular vesicle (EV) analyses validate the use of L1 cell adhesion molecule (L1CAM) as a reliable biomarker of neuron-derived EVs. J Extracell Vesicles 13(6):e12459","journal-title":"J Extracell Vesicles"},{"issue":"37","key":"6052_CR100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi3647","volume":"9","author":"Y You","year":"2023","unstructured":"You Y et al (2023) ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids. Sci Adv 9(37):eadi3647","journal-title":"Sci Adv"},{"issue":"1","key":"6052_CR101","doi-asserted-by":"publisher","first-page":"133","DOI":"10.20517\/evcna.2023.13","volume":"4","author":"E Eitan","year":"2023","unstructured":"Eitan E et al (2023) Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer\u2019s disease: novel methodology and clinical proof of concept. Extracell Vesicles Circ Nucl Acids 4(1):133\u2013150","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"3","key":"6052_CR102","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12017-021-08696-6","volume":"24","author":"G Yousif","year":"2022","unstructured":"Yousif G et al (2022) Exosomes derived neuronal markers: immunoaffinity isolation and characterization. Neuromolecular Med 24(3):339\u2013351","journal-title":"Neuromolecular Med"},{"issue":"2","key":"6052_CR103","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.14-262048","volume":"29","author":"D Kapogiannis","year":"2015","unstructured":"Kapogiannis D et al (2015) Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease. FASEB J 29(2):589\u2013596","journal-title":"FASEB J"},{"key":"6052_CR104","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"XY Cao","year":"2017","unstructured":"Cao XY et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399","journal-title":"Neurosci Lett"},{"issue":"10","key":"6052_CR105","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1074\/jbc.RA118.004825","volume":"294","author":"JM Silverman","year":"2019","unstructured":"Silverman JM et al (2019) CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem 294(10):3744\u20133759","journal-title":"J Biol Chem"},{"issue":"5-6","key":"6052_CR106","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener 15(5\u20136):351\u2013356","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"6052_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1106497","volume":"15","author":"YF Cheng","year":"2023","unstructured":"Cheng YF et al (2023) Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis. Front Aging Neurosci 15:1106497","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"6052_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12031-025-02315-w","volume":"75","author":"Y Al Ojaimi","year":"2025","unstructured":"Al Ojaimi Y et al (2025) Metabolomic and proteomic profiling of serum-derived extracellular vesicles from early-stage amyotrophic lateral sclerosis patients. J Mol Neurosci 75(1):21","journal-title":"J Mol Neurosci"},{"key":"6052_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnagi.2020.00004","volume":"12","author":"A Iarkov","year":"2020","unstructured":"Iarkov A et al (2020) Strategies for the treatment of Parkinson\u2019s disease: beyond dopamine. Front Aging Neurosci 12:4","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"6052_CR110","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1567205016666190301111120","volume":"16","author":"FH Bazzari","year":"2019","unstructured":"Bazzari FH, Abdallah DM, El-Abhar HS (2019) Pharmacological interventions to attenuate Alzheimer\u2019s disease progression: the story so far. Curr Alzheimer Res 16(3):261\u2013277","journal-title":"Curr Alzheimer Res"},{"key":"6052_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112636","author":"X Qi","year":"2024","unstructured":"Qi X et al (2024) Disease modifying monoclonal antibodies and symptomatic pharmacological treatment for Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12112636","journal-title":"Biomedicines"},{"issue":"1","key":"6052_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737175.2023.2174018","volume":"23","author":"Y Sun","year":"2023","unstructured":"Sun Y, Li X, Bedlack R (2023) An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother 23(1):1\u20137","journal-title":"Expert Rev Neurother"},{"key":"6052_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040433","author":"K Shibuya","year":"2022","unstructured":"Shibuya K et al (2022) Neuronal hyperexcitability and free radical toxicity in amyotrophic lateral sclerosis: established and future targets. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15040433","journal-title":"Pharmaceuticals (Basel)"},{"key":"6052_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2026.112571","volume":"145","author":"Z Jiang","year":"2026","unstructured":"Jiang Z et al (2026) Astragaloside IV enhances autophagy to suppress endoplasmic reticulum stress and pyroptosis after spinal cord injury. Cell Signal 145:112571","journal-title":"Cell Signal"},{"key":"6052_CR115","doi-asserted-by":"crossref","unstructured":"Aliakbari F et al (2026)\u00a0Exosomes as advanced nanocarriers: overcoming the blood-brain barrier for targeted therapeutic delivery in neurodegenerative diseases. Curr Drug Deliv","DOI":"10.2174\/0115672018430706251211094801"},{"issue":"11","key":"6052_CR116","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","volume":"43","author":"M Ding","year":"2018","unstructured":"Ding M et al (2018) Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer\u2019s disease. Neurochem Res 43(11):2165\u20132177","journal-title":"Neurochem Res"},{"issue":"20","key":"6052_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202201203","volume":"11","author":"L Leggio","year":"2022","unstructured":"Leggio L et al (2022) Small extracellular vesicles secreted by nigrostriatal astrocytes rescue cell death and preserve mitochondrial function in Parkinson\u2019s disease. Adv Healthc Mater 11(20):e2201203","journal-title":"Adv Healthc Mater"},{"key":"6052_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103651","author":"R Bonafede","year":"2020","unstructured":"Bonafede R et al (2020) ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21103651","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6052_CR119","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1007\/s12035-024-03936-9","volume":"61","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Activating MC4R promotes functional recovery by repressing oxidative stress-mediated AIM2 activation post-spinal cord injury. Mol Neurobiol 61(8):6101\u20136118","journal-title":"Mol Neurobiol"},{"key":"6052_CR120","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"EV Batrakova","year":"2015","unstructured":"Batrakova EV, Kim MS (2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396\u2013405","journal-title":"J Control Release"},{"issue":"48","key":"6052_CR121","doi-asserted-by":"publisher","first-page":"14695","DOI":"10.1021\/acs.langmuir.2c02258","volume":"38","author":"T Yasuda","year":"2022","unstructured":"Yasuda T et al (2022) Fluorescence spectroscopic analysis of lateral and transbilayer fluidity of exosome membranes. Langmuir 38(48):14695\u201314703","journal-title":"Langmuir"},{"issue":"5","key":"6052_CR122","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","volume":"11","author":"D Feng","year":"2010","unstructured":"Feng D et al (2010) Cellular internalization of exosomes occurs through phagocytosis. Traffic 11(5):675\u2013687","journal-title":"Traffic"},{"issue":"2","key":"6052_CR123","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1182\/blood-2013-03-489732","volume":"123","author":"SC Saunderson","year":"2014","unstructured":"Saunderson SC et al (2014) CD169 mediates the capture of exosomes in spleen and lymph node. Blood 123(2):208\u2013216","journal-title":"Blood"},{"key":"6052_CR124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biomaterials.2016.07.003","volume":"105","author":"DC Watson","year":"2016","unstructured":"Watson DC et al (2016) Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105:195\u2013205","journal-title":"Biomaterials"},{"issue":"4","key":"6052_CR125","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H et al (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med 18(4):499\u2013511","journal-title":"Tissue Eng Regen Med"},{"key":"6052_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030672","author":"H Choi","year":"2022","unstructured":"Choi H et al (2022) Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14030672","journal-title":"Pharmaceutics"},{"key":"6052_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124407","author":"WA Banks","year":"2020","unstructured":"Banks WA et al (2020) Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124407","journal-title":"Int J Mol Sci"},{"key":"6052_CR128","doi-asserted-by":"publisher","unstructured":"Pantazopoulou M, Lamprokostopoulou A, Karampela DS et al (2023) Differential intracellular trafficking of extracellular vesicles in microglia and astrocytes. Cell Mol Life Sci 80:193. https:\/\/doi.org\/10.1007\/s00018-023-04841-5","DOI":"10.1007\/s00018-023-04841-5"},{"key":"6052_CR129","doi-asserted-by":"publisher","first-page":"24722","DOI":"10.3402\/jev.v3.24722","volume":"3","author":"M Chivet","year":"2014","unstructured":"Chivet M et al (2014) Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons. J Extracell Vesicles 3:24722","journal-title":"J Extracell Vesicles"},{"key":"6052_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H et al (2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 9:751079","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"6052_CR131","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1021\/acsabm.4c00296","volume":"7","author":"G Kim","year":"2024","unstructured":"Kim G et al (2024) Fluorescent chiral quantum dots to unveil origin-dependent exosome uptake and cargo release. ACS Appl Bio Mater 7(5):3358\u20133374","journal-title":"ACS Appl Bio Mater"},{"issue":"9","key":"6052_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12356","volume":"12","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion. J Extracell Vesicles 12(9):e12356","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"6052_CR133","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12987-022-00334-y","volume":"19","author":"P Alam","year":"2022","unstructured":"Alam P et al (2022) Polarized \u03b1-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers. Fluids Barriers CNS 19(1):37","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"6052_CR134","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/cr.2017.62","volume":"27","author":"B Xu","year":"2017","unstructured":"Xu B et al (2017) Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res 27(7):882\u2013897","journal-title":"Cell Res"},{"issue":"1","key":"6052_CR135","doi-asserted-by":"publisher","first-page":"15731","DOI":"10.1038\/s41598-023-42485-4","volume":"13","author":"MI Khan","year":"2023","unstructured":"Khan MI et al (2023) Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer\u2019s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways. Sci Rep 13(1):15731","journal-title":"Sci Rep"},{"key":"6052_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148919","volume":"1835","author":"W Jiang","year":"2024","unstructured":"Jiang W et al (2024) M1-type microglia-derived exosomes contribute to blood-brain barrier damage. Brain Res 1835:148919","journal-title":"Brain Res"},{"key":"6052_CR137","first-page":"322","volume":"50","author":"L Yu","year":"2025","unstructured":"Yu L et al (2025) Exomeres and supermeres: current advances and perspectives. Bioact Mater 50:322\u2013343","journal-title":"Bioact Mater"},{"key":"6052_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114535","volume":"190","author":"N Yom-Tov","year":"2022","unstructured":"Yom-Tov N, Guy R, Offen D (2022) Extracellular vesicles over adeno-associated viruses: advantages and limitations as drug delivery platforms in precision medicine. Adv Drug Deliv Rev 190:114535","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"6052_CR139","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7150\/thno.117143","volume":"16","author":"Q Huang","year":"2026","unstructured":"Huang Q et al (2026) Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics 16(1):545\u2013579","journal-title":"Theranostics"},{"key":"6052_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115461","volume":"215","author":"J Bader","year":"2024","unstructured":"Bader J, Brigger F, Leroux JC (2024) Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids. Adv Drug Deliv Rev 215:115461","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"6052_CR141","first-page":"480","volume":"14","author":"X Niu","year":"2019","unstructured":"Niu X, Chen J, Gao J (2019) Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances. Asian J Pharm Sci 14(5):480\u2013496","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"6052_CR142","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1039\/C6MB00082G","volume":"12","author":"A Abramowicz","year":"2016","unstructured":"Abramowicz A, Widlak P, Pietrowska M (2016) Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation. Mol Biosyst 12(5):1407\u20131419","journal-title":"Mol Biosyst"},{"key":"6052_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194684","author":"N Ludwig","year":"2019","unstructured":"Ludwig N, Whiteside TL, Reichert TE (2019) Challenges in exosome isolation and analysis in health and disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194684","journal-title":"Int J Mol Sci"},{"key":"6052_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S et al (2020) Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact 20:100261","journal-title":"NanoImpact"},{"key":"6052_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","author":"H Zeng","year":"2023","unstructured":"Zeng H et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cells. https:\/\/doi.org\/10.3390\/cells12101416","journal-title":"Cells"},{"issue":"10","key":"6052_CR146","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1021\/acsbiomaterials.4c00856","volume":"10","author":"W Ahmed","year":"2024","unstructured":"Ahmed W et al (2024) Engineering approaches for exosome cargo loading and targeted delivery: biological versus chemical perspectives. ACS Biomater Sci Eng 10(10):5960\u20135976","journal-title":"ACS Biomater Sci Eng"},{"key":"6052_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010038","author":"AJ Lenna\u00e1rd","year":"2021","unstructured":"Lenna\u00e1rd AJ et al (2021) Optimised electroporation for loading of extracellular vesicles with doxorubicin. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14010038","journal-title":"Pharmaceutics"},{"issue":"13","key":"6052_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12163","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C et al (2021) Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour. J Extracell Vesicles 10(13):e12163","journal-title":"J Extracell Vesicles"},{"key":"6052_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117248","volume":"178","author":"F Soltanmohammadi","year":"2024","unstructured":"Soltanmohammadi F et al (2024) Current knowledge of hybrid nanoplatforms composed of exosomes and organic\/inorganic nanoparticles for disease treatment and cell\/tissue imaging. Biomed Pharmacother 178:117248","journal-title":"Biomed Pharmacother"},{"key":"6052_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020267","author":"DA Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez DA, Vader P (2022) Extracellular vesicle-based hybrid systems for advanced drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14020267","journal-title":"Pharmaceutics"},{"key":"6052_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123184","volume":"319","author":"X Xuanyuan","year":"2025","unstructured":"Xuanyuan X et al (2025) Harnessing prazosin for tumors: liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition. Biomaterials 319:123184","journal-title":"Biomaterials"},{"key":"6052_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117485","volume":"289","author":"H Zhou","year":"2025","unstructured":"Zhou H et al (2025) Exosome\/liposome hybrid nanovesicles for enhanced phototherapy and boosted anti-tumor immunity against melanoma. Eur J Med Chem 289:117485","journal-title":"Eur J Med Chem"},{"key":"6052_CR153","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","volume":"365","author":"R Wang","year":"2024","unstructured":"Wang R et al (2024) Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. J Control Release 365:331\u2013347","journal-title":"J Control Release"},{"key":"6052_CR154","first-page":"704","volume":"60","author":"J Zhang","year":"2026","unstructured":"Zhang J et al (2026) 3D-MSCs apoptotic bodies-integrated conductive hydrogel mitigates spinal cord injury via immunoregulation and alleviating neuronal pyroptosis. Bioact Mater 60:704\u2013723","journal-title":"Bioact Mater"},{"key":"6052_CR155","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","volume":"356","author":"L Nieland","year":"2023","unstructured":"Nieland L et al (2023) Engineered EVs designed to target diseases of the CNS. J Control Release 356:493\u2013506","journal-title":"J Control Release"},{"issue":"8","key":"6052_CR156","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.7150\/thno.52496","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q et al (2021) Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion. Theranostics 11(8):3916\u20133931","journal-title":"Theranostics"},{"key":"6052_CR157","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.actbio.2019.05.054","volume":"94","author":"S Rayamajhi","year":"2019","unstructured":"Rayamajhi S et al (2019) Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Acta Biomater 94:482\u2013494","journal-title":"Acta Biomater"},{"issue":"32","key":"6052_CR158","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303617","volume":"10","author":"M Sun","year":"2023","unstructured":"Sun M et al (2023) Beyond extracellular vesicles: hybrid membrane nanovesicles as emerging advanced tools for biomedical applications. Adv Sci (Weinh) 10(32):e2303617","journal-title":"Adv Sci (Weinh)"},{"key":"6052_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17080990","author":"N Verma","year":"2025","unstructured":"Verma N, Arora S (2025) Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and future directions. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17080990","journal-title":"Pharmaceutics"},{"key":"6052_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113843","volume":"176","author":"A Grangier","year":"2021","unstructured":"Grangier A et al (2021) Technological advances towards extracellular vesicles mass production. Adv Drug Deliv Rev 176:113843","journal-title":"Adv Drug Deliv Rev"},{"key":"6052_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.hybadv.2025.100513","volume":"11","author":"S Dargude","year":"2025","unstructured":"Dargude S, Chabukswar A, Jagdale S (2025) Breaking the brain barrier: hybrid nanoparticle-enabled delivery for next-gen neurotherapeutics. Hybrid Adv 11:100513","journal-title":"Hybrid Adv"},{"issue":"1","key":"6052_CR162","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40035-024-00436-7","volume":"13","author":"C Gao","year":"2024","unstructured":"Gao C et al (2024) Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures. Transl Neurodegener 13(1):43","journal-title":"Transl Neurodegener"},{"issue":"2","key":"6052_CR163","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1021\/acsnano.0c09681","volume":"15","author":"M Hu","year":"2021","unstructured":"Hu M et al (2021) Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy. ACS Nano 15(2):3123\u20133138","journal-title":"ACS Nano"},{"key":"6052_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102148","volume":"55","author":"J Liu","year":"2024","unstructured":"Liu J et al (2024) T lymphocyte-derived immunogenic hybrid nanovesicles for immunosuppression reversion and boosted photothermal immunotherapy. Nano Today 55:102148","journal-title":"Nano Today"},{"issue":"10","key":"6052_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70175","volume":"14","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) Hybrid extracellular vesicles with combined functional properties from mesenchymal stem cells and astrocytes for targeted neurodegenerative disease applications. J Extracell Vesicles 14(10):e70175","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"6052_CR166","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4155\/tde-2023-0019","volume":"14","author":"SR Babu","year":"2023","unstructured":"Babu SR et al (2023) Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review. Ther Deliv 14(9):571\u2013594","journal-title":"Ther Deliv"},{"key":"6052_CR167","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.2147\/IJN.S442876","volume":"19","author":"EY Lin","year":"2024","unstructured":"Lin EY et al (2024) Engineered exosomes containing microRNA-29b-2 and targeting the somatostatin receptor reduce presenilin 1 expression and decrease the \u03b2-amyloid accumulation in the brains of mice with Alzheimer\u2019s disease. Int J Nanomedicine 19:4977\u20134994","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"6052_CR168","doi-asserted-by":"publisher","DOI":"10.1080\/15476278.2025.2489673","volume":"21","author":"L Zhang","year":"2025","unstructured":"Zhang L (2025) MicroRNA-214-3p delivered by bone marrow mesenchymal stem cells-secreted exosomes affects oxidative stress in Alzheimer\u2019s disease rats by targeting CD151. Organogenesis 21(1):2489673","journal-title":"Organogenesis"},{"issue":"759","key":"6052_CR169","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi4830","volume":"16","author":"J Han","year":"2024","unstructured":"Han J et al (2024) Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer\u2019s disease. Sci Transl Med 16(759):eadi4830","journal-title":"Sci Transl Med"},{"issue":"1","key":"6052_CR170","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-023-04461-4","volume":"21","author":"Y Geng","year":"2023","unstructured":"Geng Y et al (2023) FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson\u2019s disease via m6A-dependent regulation of ATM mRNA. J Transl Med 21(1):652","journal-title":"J Transl Med"},{"key":"6052_CR171","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"23","author":"Q Li","year":"2021","unstructured":"Li Q et al (2021) Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther Nucleic Acids 23:1334\u20131344","journal-title":"Mol Ther Nucleic Acids"},{"key":"6052_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J et al (2021) Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 148:105218","journal-title":"Neurobiol Dis"},{"key":"6052_CR173","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba3967","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020) Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aba3967","journal-title":"Sci Adv"},{"issue":"11","key":"6052_CR174","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","volume":"18","author":"W Kong","year":"2024","unstructured":"Kong W et al (2024) Ultrasound-assisted CRISPRi-exosome for epigenetic modification of \u03b1-synuclein gene in a mouse model of Parkinson\u2019s disease. ACS Nano 18(11):7837\u20137851","journal-title":"ACS Nano"},{"issue":"4","key":"6052_CR175","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.7150\/thno.104698","volume":"15","author":"H Yu","year":"2025","unstructured":"Yu H et al (2025) Optimized circular RNA vaccines for superior cancer immunotherapy. Theranostics 15(4):1420\u20131438","journal-title":"Theranostics"},{"issue":"3","key":"6052_CR176","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2016.09.069","volume":"479","author":"M Lee","year":"2016","unstructured":"Lee M et al (2016) Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun 479(3):434\u2013439","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6052_CR177","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12951-024-02764-2","volume":"22","author":"J Zhou","year":"2024","unstructured":"Zhou J et al (2024) Intranasal delivery of small extracellular vesicles reduces the progress of amyotrophic lateral sclerosis and the overactivation of complement-coagulation cascade and NF-\u0138B signaling in SOD1(G93A) mice. J Nanobiotechnology 22(1):503","journal-title":"J Nanobiotechnology"},{"key":"6052_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137493","volume":"816","author":"T Gschwendtberger","year":"2023","unstructured":"Gschwendtberger T et al (2023) Protective effects of EVs\/exosomes derived from permanently growing human MSC on primary murine ALS motor neurons. Neurosci Lett 816:137493","journal-title":"Neurosci Lett"},{"issue":"4","key":"6052_CR179","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4103\/NRR.NRR-D-23-01815","volume":"20","author":"PJ Goldschmidt-Clermont","year":"2025","unstructured":"Goldschmidt-Clermont PJ et al (2025) Treating amyotrophic lateral sclerosis with allogeneic Schwann cell-derived exosomal vesicles: a case report. Neural Regen Res 20(4):1207\u20131216","journal-title":"Neural Regen Res"},{"key":"6052_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102121","volume":"50","author":"N Dilsiz","year":"2024","unstructured":"Dilsiz N (2024) A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications. Transl Oncol 50:102121","journal-title":"Transl Oncol"},{"key":"6052_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61111930","author":"MA Aljohani","year":"2025","unstructured":"Aljohani MA (2025) Exosomes in clinical laboratory: from biomarker discovery to diagnostic implementation. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina61111930","journal-title":"Medicina (Kaunas)"},{"key":"6052_CR182","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8884642","author":"M He","year":"2021","unstructured":"He M et al (2021) Diagnostic and therapeutic potential of exosomal MicroRNAs for neurodegenerative diseases. Neural Plast. https:\/\/doi.org\/10.1155\/2021\/8884642","journal-title":"Neural Plast"},{"issue":"5","key":"6052_CR183","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14348\/molcells.2022.2033","volume":"45","author":"SH Ahn","year":"2022","unstructured":"Ahn SH et al (2022) Manufacturing therapeutic exosomes: from bench to industry. Mol Cells 45(5):284\u2013290","journal-title":"Mol Cells"},{"key":"6052_CR184","doi-asserted-by":"publisher","unstructured":"Vani D, Ethiraj T, Ponnusamy S, Devi R, Philip AE (2025) Exosomes as next generation carriers for brain drug delivery. Engineering, formulation, characterization, and neurotherapeutic applications. Pharm Nanotechnol 13:e22117385383438.  https:\/\/doi.org\/10.2174\/0122117385383438250526063154","DOI":"10.2174\/0122117385383438250526063154"},{"issue":"21\u201322","key":"6052_CR185","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/hum.2024.249","volume":"36","author":"A Abdellatif","year":"2025","unstructured":"Abdellatif A et al (2025) Advancing potency assay development for advanced therapy medicinal products: a comprehensive approach and regulatory insights. Hum Gene Ther 36(21\u201322):1371\u20131386","journal-title":"Hum Gene Ther"},{"issue":"5","key":"6052_CR186","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/wnan.1395","volume":"8","author":"EV Batrakova","year":"2016","unstructured":"Batrakova EV, Kim MS (2016) Development and regulation of exosome-based therapy products. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8(5):744\u2013757","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"6052_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/srep22519","volume":"6","author":"E Willms","year":"2016","unstructured":"Willms E et al (2016) Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 6:22519","journal-title":"Sci Rep"},{"issue":"14","key":"6052_CR188","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1039\/D0LC00431F","volume":"20","author":"G Huang","year":"2020","unstructured":"Huang G et al (2020) Emerging technologies for profiling extracellular vesicle heterogeneity. Lab Chip 20(14):2423\u20132437","journal-title":"Lab Chip"},{"issue":"6","key":"6052_CR189","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/pmic.70078","volume":"26","author":"Y Hu","year":"2026","unstructured":"Hu Y et al (2026) See the unseen: rapid, multiparametric single-particle analysis of extracellular vesicles with nano-flow cytometry. Proteomics 26(6):38\u201351","journal-title":"Proteomics"},{"issue":"1","key":"6052_CR190","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1038\/s41467-025-62613-0","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu J et al (2025) Single extracellular vesicle imaging via rolling circle amplification-expansion microscopy. Nat Commun 16(1):7498","journal-title":"Nat Commun"},{"key":"6052_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116629","volume":"263","author":"H-J Lim","year":"2024","unstructured":"Lim H-J et al (2024) Nanoscale single-vesicle analysis: high-throughput approaches through AI-enhanced super-resolution image analysis. Biosens Bioelectron 263:116629","journal-title":"Biosens Bioelectron"},{"key":"6052_CR192","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","volume":"469","author":"H Zheng","year":"2021","unstructured":"Zheng H et al (2021) Investigation of \u03b1-synuclein species in plasma exosomes and the oligomeric and phosphorylated \u03b1-synuclein as potential peripheral biomarker of Parkinson\u2019s disease. Neuroscience 469:79\u201390","journal-title":"Neuroscience"},{"key":"6052_CR193","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2019","unstructured":"Cao Z et al (2019) \u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 696:114\u2013120","journal-title":"Neurosci Lett"},{"issue":"2","key":"6052_CR194","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00018-020-03619-3","volume":"78","author":"D Gagliardi","year":"2021","unstructured":"Gagliardi D et al (2021) Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers. Cell Mol Life Sci 78(2):561\u2013572","journal-title":"Cell Mol Life Sci"},{"key":"6052_CR195","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejpb.2017.07.010","volume":"119","author":"M Lu","year":"2017","unstructured":"Lu M et al (2017) Recent advances on extracellular vesicles in therapeutic delivery: challenges, solutions, and opportunities. Eur J Pharm Biopharm 119:381\u2013395","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06052-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:01:38Z","timestamp":1784127698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06052-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":195,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6052"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06052-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT and Grammarly to improve language, grammar, and readability. After using these tools, the authors reviewed and edited the content as needed and took full responsibility for the publication\u2019s content.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"768"}}